NCT04709900

Brief Summary

The purpose of the DYNAMITE trial (Dynamic CT stress myocardial perfusion, CT fractional flow reserve (FFR-CT) and coronary CT angiography for optimized treatment strategy in patients with chest pain syndromes) is to determine the ability of combined anatomical and functional cardiac CT imaging to improve morbidity and mortality in patients with suspected or known ischemic heart disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for not_applicable coronary-artery-disease

Timeline
68mo left

Started Dec 2021

Longer than P75 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Dec 2021Dec 2031

First Submitted

Initial submission to the registry

January 12, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 14, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

December 3, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2031

Expected
Last Updated

December 12, 2022

Status Verified

December 1, 2022

Enrollment Period

3 years

First QC Date

January 12, 2021

Last Update Submit

December 8, 2022

Conditions

Keywords

Cardiac CTChest painCoronary artery disease

Outcome Measures

Primary Outcomes (1)

  • Major Adverse Cardiovascular Events

    cardiovascular death, acute myocardial infarction, stroke or hospitalization for heart failure

    3 years

Secondary Outcomes (15)

  • Individual components of the primary endpoint

    3 years

  • Acute myocardial infarction stratified by subtype

    12 months

  • Hospitalization due to unstable angina pectoris, bleeding, pacemaker and/or implantable/cardioverter defibrillator implantation, surgical or percutaneous heart valve treatment

    3 years

  • All-cause mortality

    3 years

  • All-cause mortality

    10 years

  • +10 more secondary outcomes

Study Arms (2)

Intervention group

ACTIVE COMPARATOR

CT angiography, FFR-CT and dynamic CT stress myocardial perfusion guided treatment strategy

Diagnostic Test: CT angiography, FFR-CT and stress CT myocardial perfusion

Standard care group

NO INTERVENTION

Evaluation and treatment strategy according to contemporary clinical practice

Interventions

The study intervention team consists of a specialist in Cardiac CT imaging, an invasive cardiologist, a thoracic surgeon and a cardiology nurse specialist. Treatment strategy defined by the study team based on CT findings involve referral for percutaneous coronary intervention, Coronary Artery Bypass surgery and/or initiation of optimal medical therapy, in addition to potential supplementary diagnostic procedures.

Intervention group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Chest pain in patients with clinically suspected or confirmed ischemic heart disease
  • Clinical indication for non-acute coronary evaluation
  • Status of coronary revascularization
  • With previous coronary revascularization - all patients
  • Without previous coronary revascularization
  • Age≥65 years - all patients with chest pain
  • Age\>50 - \<65 years - typical angina pectoris and at least one cardiovascular risk factor and/or previous myocardial infarction
  • Typical angina requiring all 3 criteria present: a) constrictive discomfort in the front of the chest or in the neck, jaw, shoulder or arm, b) precipitated by physical exertion c) relieved by rest or nitrates within 5 min.
  • Cardiovascular risk factors: hypertension, diabetes, hypercholesterolemia, current smoking, family history of ischemic heart disease, previous stroke, peripheral artery disease

You may not qualify if:

  • Persistent chest pain and signs of ongoing acute myocardial ischemia requiring acute coronary intervention
  • Hospitalization and discharge with the confirmed diagnosis acute coronary syndrome (STEMI or NSTEMI) within the last 6 months
  • Severe valvular heart disease as primary diagnosis and/or in potential need of percutaneous or surgical valve treatment
  • Known severe heart failure (LVEF less than 35%)
  • Language, cultural or mental factors preventing the patient from understanding the informed consent form
  • Known atrial fibrillation
  • Known renal impairment (estimated Glomerular Filtration Rate below \<30 ml/min)
  • Known x-ray contrast allergy
  • Known intolerance to adenosine infusion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen

Copenhagen, 2100, Denmark

RECRUITING

MeSH Terms

Conditions

Coronary Artery DiseaseHeart FailureStrokeCardiovascular DiseasesChest Pain

Interventions

Computed Tomography Angiography

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Tomography, X-Ray ComputedImage Interpretation, Computer-AssistedDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisMultimodal ImagingRadiographic Image EnhancementImage EnhancementPhotographyRadiographyTomography, X-RayTomography

Study Officials

  • Klaus F Kofoed, MD

    Department of Cardiology, Rigshospitalet, University of Copenhagen, Denmark

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Klaus F Kofoed, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical associated Research Professor

Study Record Dates

First Submitted

January 12, 2021

First Posted

January 14, 2021

Study Start

December 3, 2021

Primary Completion

December 1, 2024

Study Completion (Estimated)

December 1, 2031

Last Updated

December 12, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will share

Following publication of the main results of the trial, anonymized data will be made available to other researchers through the Zenodo open data repository.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Statistical Analysis Plan and study protocol a time of publication
Access Criteria
Curated by principle investigator according to contemporary law

Locations